Biotechnology and Pharmaceutical Recruitment
Life Science Partner: A Leading Biotech and Pharmaceutical Executive Recruitment Agency
Life Science Partner: A Leading Biotech and Pharmaceutical Executive Recruitment Agency
Since 2002, we’ve partnered with some of the world’s top pharmaceutical companies to develop breakthrough biopharmaceuticals. We focus on placing transformational leaders who push innovation and improve patient outcomes.
Our recruitment services help pharmaceutical manufacturers solve market challenges, giving patients access to new prescription drugs while boosting company growth and shareholder value. By placing top talent, we ensure our clients stay ahead in a competitive market.
At Life Science Partner, we also contribute to the availability of biosimilars—“generic” versions of biological drugs.
Thanks to the Biologics Price Competition and Innovation Act (BPCIA) of 2009, pharmaceutical manufacturers can now bring biosimilar drugs to market without the need for lengthy trials. This law has made it easier to approve and launch biosimilar drugs in the United States.
Our team helped build Hospira’s leadership team by placing several key executives. We recruited Tom Vanden Boom, Global VP of Biologics Research and Development, to lead Hospira’s biosimilar development.
Following this, we brought in Dr. Scott Treiber, VP of Clinical Operations, to oversee clinical strategies. We also added Seema Kumbhat, MD, as Medical Director of Device Development. Life Science Partner also recruited Neil Schauer, PhD, as Senior Director of Biologics Process Development.
Finally, Thomas Nikolai joined as Senior Director of External Collaborations.
With this strong leadership team, Hospira emerged as a major player in biosimilar drug development. This led to Pfizer’s acquisition of Hospira in 2015 for $17 billion. As a result, Pfizer’s presence in the biosimilars market expanded.

Life Science Partner announces the recruitment of Tom Vanden Boom, PhD, a senior biopharmaceutical executive in the development, manufacturing and commercial launch of biologic products.
Hospira is a global specialty pharmaceutical and medication delivery company that develops, manufactures and markets products that help improve the safety, effectiveness and costs of patient care.
In his most recent role at Bristol-Myers Squibb, Vanden Boom was responsible for leading the Biologics Manufacturing Launch Teams for global technical operations manufacturing and supply chain activities supporting the commercial launch of all new biologic products for the company.
For more detailed information, visit the Vanden Boom press release.
Life Science Partner has also played a pivotal role in helping Contract Development and Manufacturing Organizations (CDMOs) grow. CDMOs are critical in developing and manufacturing biologics, such as vaccines and gene therapies, for pharmaceutical companies.
In 2012, we placed Jesse McCool, PhD, at Cytovance Biologics as VP of Microbial Services. His leadership helped Cytovance scale its microbial services, which solidified their role in the biotechnology industry.
McCool later became Cytovance’s Chief Scientific Officer and helped grow the company into a top biotechnology recruiting partner. He has since co-founded Wheeler Bio, a next-gen CDMO. We then recruited Stewart McNaull, PhD, as SVP and Chief Business Officer to further drive Wheeler Bio’s strategy.
The global biologics CDMO market was worth over $16 billion in 2023 and is expected to exceed $25 billion by 2028.
This growth is driven by the increasing number of biologic drugs, including monoclonal antibodies and cell therapies, in development. As a result, job demand in this industry will remain strong for years to come.

Wheeler Bio, a CDMO, retained Life Science Partner as a biotechnology recruitment firm to find their Chief Development Officer.
Beginning in January 2023, Brian Berquist, PhD, began leading the team in Wheeler Bio’s newstate-of-the-art Oklahoma City facility, where they have revolutionized the speed of drug discovery and democratized the innovation-to-impact process.
For more detailed information, visit the Brian Berquist press release.
Life Science Partner has extensive experience recruiting leaders to help companies meet FDA compliance standards for pharmaceutical marketing. Pharmaceutical companies must adhere to strict rules for promoting drugs and ensuring they do not promote off-label uses.
One of our clients, Allergan, faced a major compliance issue related to charges from the FDA for off-label promotion of Botox.
The FDA accused Allergan of marketing Botox for uses that were not officially approved, such as treating migraine headaches, muscle stiffness, and overactive bladder. These practices violated FDA regulations, which strictly prohibit pharmaceutical companies from promoting drugs for unapproved uses.
As a result, Allergan had to deal with legal actions, fines, and more scrutiny from regulators. They reached a settlement with the Department of Justice (DOJ), agreeing to pay large penalties and follow stricter oversight of their marketing practices to ensure compliance with FDA standards.
Life Science Partner helped Allergan build a strong compliance team to navigate these challenges. Our expertise in pharmaceutical recruitment allowed Allergan to meet FDA regulations, protect their business, and avoid future legal risks.
In response to compliance challenges, including allegations of off-label promotion of Botox, Allergan turned to Life Science Partner to build their compliance leadership team.
We placed Wes Porter as VP and Deputy Compliance Officer, strengthening Allergan’s compliance framework. We also placed Nancy Grygiel as Senior Director of Corporate Compliance to ensure international regulatory standards were met.
These strategic hires helped Allergan improve its global compliance infrastructure, positioning the company for its $63 billion acquisition by AbbVie in 2020.

Life Science Partner announces the recruitment of Nancy Grygiel, an experienced global compliance executive, to Allergan, Inc. to become Senior Director, Corporate Compliance, International for the company.
Allergan is a technology-driven, multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices in the areas of eye care, neurosciences, medical dermatology and urologics.
For more detailed information, visit the Nancy Grygiel press release.

For over 20 years, Life Science Partner has specialized in recruiting top leaders for the pharmaceutical and biotechnology industries.
We focus on life science recruitment for roles such as Chief Executive Officers (CEOs), Chief Medical Officers (CMOs), and Regulatory Affairs Leaders.
Founded by Dr. Tom Callaway, Life Science Partner combines scientific expertise and business insight. We help pharmaceutical recruitment agencies and biotechnology recruiting firms find high-quality candidates who drive growth and innovation.
Our principal-led model ensures every search is customized to meet client needs. We understand the complexities of the pharmaceutical industry and biotechnology sector. Whether you’re a large pharmaceutical company or an emerging biotech firm, we can help you recruit top talent.
We have a proprietary database of over 40,000 qualified candidates in the biotech and pharmaceutical sectors. This deep network allows us to quickly find the right leaders for your team. Whether you need talent in clinical operations, regulatory affairs, or commercial leadership, we’ve got you covered.
But we don’t just place executives—we build long-term relationships. We ensure the leaders we place align with your company’s vision and culture, reducing turnover and creating lasting success. Our team understands the lifecycle of a biopharma company, from research and development to commercialization.

For over two decades, Life Science Partner has been a trusted partner for biotechnology and pharmaceutical executive recruiters. Our hands-on approach, deep industry knowledge, and strategic research help us consistently deliver quality candidates who drive long-term success.
As recruiters in the pharmaceutical industry, we help our clients lead in the fast-paced world of life sciences. This includes top pharmaceutical companies, biotechnology recruitment agencies, and pharmaceutical executive search firms.
Contact Life Science Partner today to find out how we can help you recruit the right leaders for your team.
Life Science Partner announces the recruitment of Stewart McNaull, PhD, to develop commercialization and expand access of Wheeler Bio’s products and service offerings. Wheeler Bio, a quickly growing CDMO, retained Life Science Partner to recruit their President and Chief Operating Officer in 2022 to accelerate their advancement as an industry leader in biologics development services. […]
Life Science Partner shares an inside conversation of their recruitment partnership with advanced biologics CDMO, Wheeler Bio. In the fall of 2022, Jesse McCool, PhD, Founder and CEO and the Board of Directors of Wheeler Bio retained Life Science Partner to recruit their new President and Chief Operating Officer. In partnership with Dr. McCool, Life […]
Life Science Partner announces the newest recruit for emerging CDMO: Wheeler Bio, a CDMO, retained Life Science Partner to recruit their Chief Development Officer to lead their process development team and accelerate their platform as a technological leader within the CDMO space. Beginning in January 2023, Brian Berquist, PhD, will lead the team in Wheeler Bio’s newstate-of-the-art […]
Life Science Partner announces the recruitment of Detra Glinatsis to lead Alloy Therapeutics’ enterprise sales growth within the CDMO industry. Alloy Therapeutics retained Life Science Partner to recruit their Vice President, Business Development and Sales to manage and accelerate their growth in biologics development services. Through a community of over 100 partners and developers, Alloy seeks […]
Life Science Partner announces the recruitment of Roger Lias, PhD, to Wheeler Bio to advance their expansion as cutting-edge biologics CDMO. Wheeler Bio, a CDMO, retained Life Science Partner to recruit their President and Chief Operating Officer to accelerate their growth as an industry leader in biologics development services. With a new state-of-the-art Oklahoma City […]
Life Science Partner is pleased to announce the recruitment of Stan Harris as Vice President, Clinical Operations for BioTissue – the newly unified brand for TissueTech, Amniox, and Bio-Tissue. BioTissue is an emerging biotechnology leader in utilizing the power of human birth tissue for regenerative healing to treat ocular surface disease and in surgical, chronic […]
Life Science Partner is pleased to announce the recruitment of Chad Kolean as Vivex Biologics’ Chief Financial Officer. Vivex Biologics is a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies. They have a diverse portfolio of current products including cellular […]
Life Science Partner is pleased to announce the recruitment of Gail Farnan as General Manager, Wound Care for Vivex Biologics. Vivex Biologics, a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies, has developed a diverse portfolio of current products including […]
Life Science Partner is pleased to announce the recruitment of Ron Hebert as Vivex Biologics’ Vice President of Marketing. Vivex Biologics, a leading regenerative medicine company that markets tissue technology products and cellular therapies. They focus on orthopaedic applications with an emphasis on spine related therapies, and have developed a diverse portfolio of current products […]
Life Science Partner is pleased to announce the recruitment of Peter Wehrly as Chief Executive Officer with Vivex Biologics. Vivex Biologics is a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies. They have a diverse portfolio of current products including […]
Life Science Partner is pleased to announce the recruitment of Dave Booth as Vice President of Quality Assurance and Regulatory Affairs with Be The Match. Booth is a seasoned quality executive with a broad background in building and leading global quality teams within the medical device industry. At Smiths Medical, Booth was Head of Quality […]
Life Science Partner is pleased to announce the recruitment of Chris Fang, MD, MBA, MHSc as Chief Medical Officer of Humacyte. Fang’s expertise in biologics and medical devices will be an invaluable asset for Humacyte, a pioneering regenerative medicine company. Humacyte’s lab-grown, acellular blood vessels have been awarded FDA fast-track status for their use in […]
Former Chief Scientific and Medical Officer Advanced Wound Care, Smith & Nephew Life Science Partner recruited Bert Slade, MD, to serve as the Vice President, Clinical Development for TissueTech. Slade has built his career in leading clinical trials, medical affairs, and regulatory approvals for medical device and pharmaceutical companies worldwide. He joins TissueTech while also […]
Former Global Pharmacovigilance and Clinical Safety Physician Otsuka Pharmaceuticals Chris Stein, MD, PhD, was recruited by Life Science Partner to serve as Director, Medical Safety Physician for Allergan where he will oversee Pharmacovigilance for Allergan’s CNS drug portfolio. In his previous role at Otsuka, Stein partnered with safety physicians at Bristol Myers Squibb to co-market […]
Former Vice President, PGT Quality Teva Pharmaceuticals Joe Jimenez, Vice President, formerly PGT Quality for Teva Pharmaceuticals has recently become Vice President, Quality Assurance and Regulatory Affairs for TissueTech, a Miami-based company producing regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal and wound care markets. Life Science Partner partnered with CEO Amy Tseng […]
Former Medical Director, Global Medical Marketing, ConvaTec Life Science Partner recruited Michel Hermans, MD, a surgically trained medical affairs executive to become Chief Medical Officer for TissueTech. Hermans joins TissueTech after serving as a biopharma consultant for his own firm and Medical Director, Global Medical Marketing for ConvaTech. Previously, Hermans served served as Medical Director […]
Former Senior Director, Global Safety Officer at The Medicines Company Life Science Partner recruited Yanshan Ma, MD, PhD, to become Senior Director, Medical Safety Physician, Internal Medicine and Infectious Diseases for Allergan. In her new role Dr. Ma will be responsible for the group’s safety strategy, pharmacovigilance and medical risk management. Dr. Ma joins Allergan […]
Former Senior Director, Research and Development At Genzyme/Sanofi Life Science Partner has recruited Gloria Matthews, DVM, PhD to become Chief Medical Officer at Histogenics. In her new role Matthews will report directly to the Chief Executive Officer, Adam Gridley, and will serve as the senior physician within Histogenics responsible for clinical direction, product strategy, medical […]
Former Vice President, Global Medical Director, Stryker Life Science Partner recruited Jon Hopper, MBChB, an accomplished physician executive to become Chief Medical Officer for Osiris Therapeutics. Osiris is the leading stem cell company focused on developing products to treat conditions in wound care, orthopedic and sports medicine markets. Hopper joins Osiris after serving as the […]
Former Global Head of Safety Surveillance for Amgen Life Science Partner recruited Andre Daniels, MBChB, Executive Director, Pharmacovigilance at Amgen to become Vice President, Head of Medical Safety Physicians at Allergan. In his new role, Daniels will lead a team of physician executives to support the four key commercial franchises and their pipeline of innovative […]
Former Director, Process Development at Lonza Biologics Life Science Partner recruited Jesse McCool, an innovative and energetic R&D leader, to become Vice President, Microbial Services for Cytovance Biologics. Founded in 2003, Cytovance is one of the premier biological contract companies of therapeutic proteins and antibodies from mammalian cell culture to microbial fermentation. “Jesse brings considerable […]
Life Science Partner recruits former Associate Director, US Pharmaceuticals Compliance and Ethics for Bristol-Myers Squibb Allergan, Inc. is a technology-driven, multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices in the areas of eye care, neurosciences, medical dermatology and urologics. The company is best known for its Botox franchise. Tina Webb, an […]
Former Director, Bioproduct Analytical Development at Eli Lilly and Company Life Science Partner announces the recruitment of Cathy Srebalus-Barnes, PhD, an experienced bioanalytical executive, to become Senior Director, Bioanalytical Sciences, Global Biologics R&D for Hospira, Inc. Hospira is a global specialty pharmaceutical and medication delivery company that develops, manufactures and markets products that help improve […]
Life Science Partner recruits former Director of Global Compliance Program at Mylan Pharmaceuticals Life Science Partner announces the recruitment of Nancy Grygiel, an experienced global compliance executive, to Allergan, Inc. to become Senior Director, Corporate Compliance, International for the company. Allergan is a technology-driven, multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, […]
Life Science Partner recruits former Vice President, Chemical and Pharmaceutical Sciences at Icagen, Inc. Life Science Partner announces the recruitment of Mark Suto, PhD, an experienced scientist and drug discovery executive, to the Southern Research Institute in Birmingham, Alabama. Southern Research Institute. With a focus on the discovery and advancement of new, small-molecule therapeutics from […]
Life Science Partner recruits former Director, Biologics, Parenteral Products at Abbott Laboratories Life Science Partner announces the recruitment of Thomas Nikolai, MS, MBA, to become Senior Director, External Biologics Collaborations and Partnerships for Hospira’s biosimilars division. Hospira is a global specialty pharmaceutical and medication delivery company that develops, manufactures and markets products that help improve […]
Life Science Partner Recruits Pain Clinical Specialist from Purdue Pharma and Co-Founder of Magidom Discovery Life Science Partner announces the recruitment of Peter Lacouture, PhD, to become Medical Director of Pain Management for Hospira. Hospira is a global specialty pharmaceutical and medication delivery company that develops, manufactures and markets products that help improve the safety, […]
Life Science Partner recruits former Director of DSP Research and Development at Millipore Corp Life Science Partner announces the recruitment of Neil Schauer, PhD, a seasoned biopharmaceutical development leader and scientist, to become Senior Director, Biologics Development for Hospira’s biosimilars division. Hospira is a global specialty pharmaceutical and medication delivery company that develops, manufactures and […]
Life Science Partner recruits former President and Chief Executive Officer of Qteros Life Science Partner announces the recruitment of William (Bill) Frey, PhD, most recently President and Chief Executive Officer for Qteros, to Georgia Pacific to lead a new business development initiative on disruptive technologies across the company. In this role, Frey will be responsible […]
Life Science Partner recruits former Executive Vice President at inVentiv Clinical Solutions Life Science Partner announces the recruitment of Scott Treiber, PhD, an experienced clinical research leader, to Hospira to become Vice President of Clinical Operations and Medical Affairs. Hospira is a $5 B global specialty pharmaceutical and medication delivery company based in Lake Forest, […]
Life Science Partner recruits former Vice President, Medical Affairs at McKesson Provider Technologies Life Science Partner announces the recruitment of Seema Kumbhat, MD to Hospira to become Medical Director, Device Development – Clinical Decision Support. Hospira is a $5 B global specialty pharmaceutical and medication delivery company based in Lake Forest, Illinois. In this new […]
Life Science Partner recruits former Director of the Biologics Manufacturing Launch Teams at Bristol-Myers Squibb Company Life Science Partner announces the recruitment of Tom Vanden Boom, PhD, a senior biopharmaceutical executive in the development, manufacturing and commercial launch of biologic products. Hospira is a global specialty pharmaceutical and medication delivery company that develops, manufactures and […]
Life Science Partner recruits former Senior Vice President, Sales and Marketing for Vermillion. Life Science Partner announces the recruitment of Steve Lundy, a top commercial executive in early-stage diagnostics companies, to MicroPhage, an early-stage company based in Longmont, Colorado. Using its proprietary bacteriophage-based technology, MicroPhage is developing rapid assays for the direct identification and drug […]
Life Science Partner recruits senior biotechnology entrepreneurial and Co-Founder and Chairman of North Carolina Innovation Foundation. Life Science Partner announces the recruitment of Max Wallace, a biotechnology CEO and innovative leader, to lead Accelerate Brain Cancer Cure, Inc. ABC2 is a not-for-profit organization established in 2001 with a for-profit mindset and a singular focus: to […]
Life Science Partner recruits former Oncology Regulatory Officer for Johnson & Johnson, Pharmaceutical and Research & Development. Life Science Partner announces the recruitment of Steve Hamburger, a global regulatory and drug development executive, to Exoxemis, Inc. Exoxemis is an early-stage biopharmaceutical research and development company focused on prevention and treatment of serious infections and the […]
Life Science Partner recruits former VP of Finance & Administration and Principal Accounting Officer of AtheroGenics, Inc. Life Science Partner announces the recruitment of Charles Deignan, an experienced pharmaceutical finance executive, to Metastatix, Inc. Metastatix is an emerging pharmaceutical company developing and commercializing effective, convenient and safe small-molecule drugs for a broad portfolio of indications […]
Life Science Partner recruits former Vice President, Globalization Projects and Preclinical Development for GlaxoSmithKline Life Science Partner announces the recruitment of Blaine Knight, an experienced scientist and drug discovery executive, to the Southern Research Institute in Birmingham, Alabama. Southern Research Institute is an independent, not-for-profit center for scientific research providing innovative leadership in scientific discovery, […]
Life Science Partner recruits former SVP, Corporate Development and Commercial Affairs of Anadys Pharmaceuticals, Inc. Life Science Partner announces the recruitment of Carol Gallagher, an experienced biotechnology and pharmaceutical executive, to Metastatix, Inc. Metastatix is an emerging pharmaceutical company developing and commercializing effective, convenient and safe small-molecule drugs for a broad portfolio of indications including […]
Life Science Partner recruits former CEO of AdipoGenix, Inc. Life Science Partner announces the recruitment of Ed Cannon, an entrepreneurial pharmaceutical executive, to AerovectRx Corporation. AerovectRx is an early-stage aerosol therapeutic development company capitalizing upon its unique AeroCell™ disposable drug cartridge to improve patient compliance, eliminate multi-user cross contamination, and deliver a wide variety of […]
Life Science Partner recruits former Group Director, Biologics Research and Development of Medtronic Sofamor Danek. Life Science Partner announces the recruitment of Jeffrey Gross, PhD, former Group Director of Biologics R & D at Medtronic Sofamor Danek in Memphis, Tennessee, as Vice President of Engineering. Angiotech is the world leader in the emerging field of […]
Life Science Partner announces recruitment of former Global President of J&J’s OrthoNeutrogena Company, a Division of Ortho-McNeil Pharmaceutical, Inc. Life Science Partner announces the appointment of Chris Dennis, a senior sales, marketing and general management executive, to Angiotech Pharmaceuticals, Inc. as the Senior VP of Sales and Marketing. Angiotech is a global specialty pharmaceutical […]
Life Science Partner recruits former President and General Manager of the EDX Division of Elan Corporation Life Science Partner announces the recruitment of John Hannon, an entrepreneurial biopharmaceutical executive, to Exoxemis, Inc. Exoxemis is an early-stage biopharmaceutical research and development company focused on prevention and treatment of serious infections and the significant and growing problem […]
Life Science Partner recruits former General Manager of PBM Nutritionals, LLC (formerly Wyeth Nutritionals) Life Science Partner announces the recruitment of Bill Wright, a senior manufacturing executive, to Osiris Therapeutics, Inc. as the Senior Director, Osteocel and Mesenchymal Stem Cell (MSC) Operations. Osiris Therapeutics develops innovative technology for isolating and expanding mesenchymal stem cells […]
Life Science Partner recruits former Director, Analytical Research and Development of Celator Pharmaceuticals Corporation Life Science Partner announces the appointment of Tom Weber, a pharmaceutical R & D executive, to Angiotech Pharmaceuticals, Inc., as the Director of Analytical Chemistry. Angiotech is a world leader in the emerging field of drug-eluting medical devices and biomaterials. With […]
Life Science Partner recruits Tim Lowinger, PhD, global leader in chemistry research and development to help propel proprietary products Life Science Partner announces the recruitment of Tim Lowinger, PhD, formerly vice president, chemistry research at Bayer Healthcare, to lead Angiotech Pharmaceuticals’ newly formed division of pharmaceutical science and chemistry. Angiotech is the world leader in the […]
Life Science Partner recruits global leader in preclinical development to help accelerate product creation and add pharmaceutical expertise Life Science Partner announces the recruitment of Andrew Penman, PhD, formerly president, preclinical development at Aptuit (a spin-out of Quintiles Transnational) to lead Angiotech Pharmaceuticals newly formed division of preclinical development. Angiotech is the world leader in […]
Life Science Partner brings clinical development and marketing talent to help launch first stem-cell therapy Life Science Partner announces today the recruitment of Lode Debrabandere, PhD, former vice president, Neuroscience Business Unit of Bristol-Myers Squibb Company to Osiris Therapeutics to become general manager of Osiris Therapeutics’ Autoimmune Diseases business unit. Osiris is a privately-held biopharmaceutical […]
Life Science Partner recruits pharmaceutical veteran and cardiology specialist as chief medical officer Life Science Partner announces the recruitment of Ross Tonkens, MD, FACP, to become the chief medical officer of Regado Biosciences. Tonkens joins the company from Quintiles Transnational where he served as senior director, medical and scientific services and global scientific head for […]
Life Science Partner recruit offers valuable experience in regulatory and commercialization strategy Life Science Partner announces the recruitment of Kurt C. Gunter, MD, as medical director, cell therapy of Hospira, a Chicago area based medical products company. Hospira is a specialty pharmaceutical and medication delivery company launched from the core global hospital products business of […]
To lead a team developing novel diagnostic services and products for prostate cancer patients Life Science Partner announces the recruitment of Dr. Gerardo “Jerry” Javier Fernandez, an anatomic pathologist, to Aureon Biosciences. Aureon is a Yonkers, New York-based company enabling personalized patient care utilizing systems pathology to develop predictive clinical tests for cancer care, as […]
Founder and Director of Immunocytochemistry Laboratory at MetPath/Quest Life Science Partner announces the recruitment of Dr. Ricardo Mesa-Tejada, a recognized leader in the field of anatomic pathology to become vice president, pathology, Aureon Biosciences Corporation. Aureon is a Yonkers, New York-based company enabling personalized patient care utilizing a systems pathology approach to develop predictive clinical […]
Leading Clinical Development of Novel Compounds for Anemia and Fibrosis Life Science Partner announced today the recruitment of Russell Ellison, MD, to become Vice President, Clinical and Medical Affairs at FibroGen, a biotechnology-based drug discovery company using its expertise in the fields of tissue fibrosis and Hypoxia-Inducible Factor (HIF) biology to discover, develop and commercialize […]
Life Science Partner places drug delivery executive to guide business development Life Science Partner announced the placement of Steven Damon as vice president, business development at Altea Therapeutics. Hired August 22, 2005, Damon will be responsible for leading activities in product licensing, product pipeline analysis and assessment of competitive products and technologies. In particular, he […]
Life Science Partner places entrepreneurial-minded sales exec to lead Cleveland Clinic’s diagnostic services spin-off Life Science Partner announces the placement of Mark R.Willig, as CEO, at Cleveland-based PrognostiX, Inc. As the company’s chief executive, Willig will lead product development and commercialization of technology while overseeing finance and marketing strategy. A medical diagnostics company founded by […]
Life Science Partner recruits industry veteran to board of directors for emerging cardiovascular diagnostics firm Life Science Partner announces the placement of Vijay Aggarwal, Ph.D., as a member of the board of directors for PrognostiX, Inc. Basing its work largely on research from The Cleveland Clinic, PrognostiX focuses on the role of inflammatory processes in […]
Life Science Partner places healthcare industry strategist and investment banker to guide medical device company. Life Science Partner announces the placement of Shelley Hartman as president and chief executive officer for GMP Companies, Inc. of Fort Lauderdale, Florida. In addition to her overall responsibilities for global strategy, finance, and operations, Hartman will direct GMP Companies’ […]
Life Science Partner connects accomplished research executive with cancer therapeutics company Life Science Partner announces the placement of Brian E. Huber, Ph.D., as chief scientific officer (CSO) at Adherex Technologies, Inc., in Research Triangle Park, North Carolina. As CSO, Huber will lead a 20-person research and development team focused on the preclinical development of compounds. […]
Life Science Partner places pharmaceutical veteran and oncology specialist as chief medical officer ATLANTA, Georgia – September 7, 2004 – Life Science Partner announces the placement of Rajesh K. Malik, M.B., Ch.B. as chief medical officer at Adherex Technologies, Inc., in Research Triangle Park, North Carolina. With the position, Malik takes responsibility for the clinical […]
To build Serologicals’ product portfolio, Life Science Partner recruits former Amersham Biotech head of North American R&D, global genomics. Life Science Partner announces the placement of Dennis W. Harris as vice president of research and development/business development and chief scientific officer at Serologicals Corporation in Norcross, Georgia. With the move, Harris becomes the senior leader […]
Life Science Partner recruits pharma finance executive with entrepreneurial and global R&D experience Life Science Partner announces the placement of James A. Klein, Jr., as chief financial officer at Adherex Technologies, Inc., to be based in its new Research Triangle Park, North Carolina headquarters. Klein assumes overall responsibility for the company’s financial health and integrity. […]
Life Science Partner connects experienced medical product engineer with radiation delivery systems company: Life Science Partner announces the placement of R. Michael Webster as senior director of product development at Proxima Therapeutics in Alpharetta, Georgia. In this new capacity, Webster assumes overall responsibility for the development and improvement of products based upon the company’s proprietary […]
Life Science Partner placement brings a record of innovation to Atlanta-based company Life Science Partner announces the placement of Dr. David J. Enscore as senior vice president, product research and development with Altea Therapeutics in Atlanta. As an integral part of Altea’s executive leadership, the 20-year industry veteran will direct pharmaceutical and clinical product development […]
